GlassScriptPhysician profile
James P Fischer
NPI 1023113321
$1,205.92
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $302 · 2020: $51.52 · 2021: $93.99 · 2023: $118 · 2024: $640.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $758.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $758.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $181.23 | 2021-2024 | |
| Amgen INC. | $173.48 | 2019-2024 | Otezla, Repatha |
| Alafair Biosciences, INC. | $146.49 | 2024 | Versawrap |
| Pfizer INC. | $94.03 | 2019-2024 | |
| Phathom Pharmaceuticals, INC. | $84.34 | 2024 | Voquezna |
| Glaxosmithkline, LLC. | $81.25 | 2020-2024 | Trelegy Ellipta, Arexvy, Shingrix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $76.97 | 2019 | |
| Novo Nordisk INC | $61.43 | 2019-2024 | Rybelsus, Ozempic, Wegovy |
| Merck Sharp & Dohme LLC | $53.25 | 2019-2024 | Capvaxive |
| Novartis Pharmaceuticals Corporation | $46.44 | 2019-2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $34.00 | 2024 | Xifaxan |
| Amarin Pharma, INC. | $22.25 | 2019 | |
| Dexcom, INC. | $21.02 | 2024 | Dexcom G6 Transmitter |
| Lucid Diagnostics INC. | $19.16 | 2023 | |
| Lundbeck LLC | $18.37 | 2024 | Rexulti |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $18.04 | 2024 | Airsupra |
| Bayer Healthcare Pharmaceuticals INC. | $17.16 | 2024 | |
| Exact Sciences Corporation | $15.56 | 2023 | Cologuard Collection Kit |
| Sumitomo Pharma America, INC. | $15.12 | 2024 | Gemtesa |
| Acella Pharmaceuticals, LLC | $13.70 | 2024 | NP Thyroid 60 |
| Preventice Services, LLC | $12.63 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Fischer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.